Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Partho Protim Adhikary

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Advanced Healthcare Materials|January 7, 2026
A Human-Based Skin-Lymphoreticular Model-on-Chip to Emulate Inflammatory Skin ConditionsZheng Tan, Partho Protim Adhikary, Dana Wörz, et al.
Nature Reviews. Materials|March 22, 2021
COVID-19 highlights the model dilemma in biomedical researchPartho Protim Adhikary, Qurrat Ul Ain, Andreas Christian Hocke, et al.
Pharmacology & Therapeutics|August 8, 2020
TSLP as druggable target - a silver-lining for atopic diseases?Partho Protim Adhikary, Zheng Tan, Brent D G Page, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|December 27, 2011
Suicidal gene therapy against tumor using reducible poly (oligo-D-arginine)Kyung-Min Kim, Young-Wook Won, Partho Protim Adhikary, et al.
Nature Materials|October 6, 2014
Oligopeptide complex for targeted non-viral gene delivery to adipocytesYoung-Wook Won, Partho Protim Adhikary, Kwang Suk Lim, et al.
EMBO Molecular Medicine|June 14, 2024
Disrupting TSLP-TSLP receptor interactions via putative small molecule inhibitors yields a novel and efficient treatment option for atopic diseasesPartho Protim Adhikary, Temilolu Idowu, Zheng Tan, et al.
EMBO Molecular Medicine|November 7, 2024
Author Correction: Disrupting TSLP-TSLP receptor interactions via putative small molecule inhibitors yields a novel and efficient treatment option for atopic diseasesPartho Protim Adhikary, Temilolu Idowu, Zheng Tan, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Advanced Healthcare Materials|January 7, 2026
A Human-Based Skin-Lymphoreticular Model-on-Chip to Emulate Inflammatory Skin ConditionsZheng Tan, Partho Protim Adhikary, Dana Wörz, et al.
Nature Reviews. Materials|March 22, 2021
COVID-19 highlights the model dilemma in biomedical researchPartho Protim Adhikary, Qurrat Ul Ain, Andreas Christian Hocke, et al.
Pharmacology & Therapeutics|August 8, 2020
TSLP as druggable target - a silver-lining for atopic diseases?Partho Protim Adhikary, Zheng Tan, Brent D G Page, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|December 27, 2011
Suicidal gene therapy against tumor using reducible poly (oligo-D-arginine)Kyung-Min Kim, Young-Wook Won, Partho Protim Adhikary, et al.
Nature Materials|October 6, 2014
Oligopeptide complex for targeted non-viral gene delivery to adipocytesYoung-Wook Won, Partho Protim Adhikary, Kwang Suk Lim, et al.
EMBO Molecular Medicine|June 14, 2024
Disrupting TSLP-TSLP receptor interactions via putative small molecule inhibitors yields a novel and efficient treatment option for atopic diseasesPartho Protim Adhikary, Temilolu Idowu, Zheng Tan, et al.
EMBO Molecular Medicine|November 7, 2024
Author Correction: Disrupting TSLP-TSLP receptor interactions via putative small molecule inhibitors yields a novel and efficient treatment option for atopic diseasesPartho Protim Adhikary, Temilolu Idowu, Zheng Tan, et al.
Pageof 1